Core Laboratories Inc. (NYSE:CLB) Shares Sold by Quest Partners LLC

Quest Partners LLC lessened its holdings in shares of Core Laboratories Inc. (NYSE:CLB) by 40.4% in the third quarter, Holdings Channel reports. The firm owned 9,653 shares of the oil and gas company’s stock after selling 6,531 shares during the period. Quest Partners LLC’s holdings in Core Laboratories were worth $179,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds have also recently bought and sold shares of the business. Vanguard Group Inc. increased its position in Core Laboratories by 0.5% during the 1st quarter. Vanguard Group Inc. now owns 5,392,034 shares of the oil and gas company’s stock worth $92,096,000 after purchasing an additional 27,701 shares in the last quarter. Disciplined Growth Investors Inc. MN increased its position in Core Laboratories by 446.8% during the 2nd quarter. Disciplined Growth Investors Inc. MN now owns 4,460,720 shares of the oil and gas company’s stock worth $90,508,000 after purchasing an additional 3,644,963 shares in the last quarter. Earnest Partners LLC increased its position in Core Laboratories by 6.3% during the 2nd quarter. Earnest Partners LLC now owns 3,286,438 shares of the oil and gas company’s stock worth $66,682,000 after purchasing an additional 195,756 shares in the last quarter. Royce & Associates LP increased its position in Core Laboratories by 9.0% during the 3rd quarter. Royce & Associates LP now owns 1,021,121 shares of the oil and gas company’s stock worth $18,921,000 after purchasing an additional 84,022 shares in the last quarter. Finally, Boston Trust Walden Corp increased its position in Core Laboratories by 1.3% during the 2nd quarter. Boston Trust Walden Corp now owns 729,760 shares of the oil and gas company’s stock worth $14,807,000 after purchasing an additional 9,468 shares in the last quarter. Institutional investors and hedge funds own 97.81% of the company’s stock.

Core Laboratories Stock Down 0.6 %

Shares of NYSE:CLB opened at $20.43 on Thursday. The company has a quick ratio of 1.79, a current ratio of 2.48 and a debt-to-equity ratio of 0.55. Core Laboratories Inc. has a 52-week low of $13.82 and a 52-week high of $25.13. The company has a 50 day moving average of $19.38 and a two-hundred day moving average of $19.52. The company has a market capitalization of $959.19 million, a price-to-earnings ratio of 31.52, a price-to-earnings-growth ratio of 1.40 and a beta of 2.35.

Core Laboratories (NYSE:CLB) last issued its quarterly earnings data on Wednesday, October 23rd. The oil and gas company reported $0.25 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.21 by $0.04. Core Laboratories had a net margin of 5.83% and a return on equity of 15.84%. The company had revenue of $134.40 million during the quarter, compared to the consensus estimate of $134.16 million. During the same quarter last year, the company earned $0.22 earnings per share. Core Laboratories’s revenue for the quarter was up 7.2% on a year-over-year basis. As a group, analysts forecast that Core Laboratories Inc. will post 0.8 earnings per share for the current fiscal year.

Core Laboratories Announces Dividend

The business also recently declared a quarterly dividend, which was paid on Monday, November 25th. Stockholders of record on Monday, November 4th were given a dividend of $0.01 per share. This represents a $0.04 dividend on an annualized basis and a dividend yield of 0.20%. The ex-dividend date of this dividend was Monday, November 4th. Core Laboratories’s payout ratio is currently 6.15%.

Wall Street Analysts Forecast Growth

A number of analysts recently issued reports on CLB shares. StockNews.com raised shares of Core Laboratories from a “sell” rating to a “hold” rating in a research report on Thursday, November 7th. Citigroup lowered their price objective on shares of Core Laboratories from $15.00 to $14.00 and set a “sell” rating for the company in a research report on Thursday, October 31st. Two analysts have rated the stock with a sell rating and three have assigned a hold rating to the stock. According to data from MarketBeat.com, the stock has a consensus rating of “Hold” and an average target price of $17.00.

About Core Laboratories

Core Laboratories Inc provides reservoir description and production enhancement services and products to the oil and gas industry in the United States, and internationally. It operates through Reservoir Description and Production Enhancement segments. The Reservoir Description segment includes the characterization of petroleum reservoir rock and reservoir fluid samples to enhance production and improve recovery of crude oil and gas from its clients' reservoirs.